While major indices have seen gains in 2025, a closer look reveals significant underperformance from several well-known stocks across the Dow Jones, Nasdaq-100, and S&P 500. This in-depth analysis unpacks the challenges faced by giants like UnitedHealth, Salesforce, Nvidia, and Deckers, and explores whether these sharp declines present unique long-term investment opportunities for the discerning investor.
The year 2025 has been a tale of two markets. For many investors, it’s been a period of solid gains, with the Dow Jones Industrial Average climbing nearly 5% and the Nasdaq-100 advancing 2.2% in January alone. Yet, beneath these buoyant headlines, a critical segment of the market has faced considerable headwinds, presenting both significant challenges and potential opportunities for those with a long-term investment horizon.
The Dow’s Stumbling Giants: UnitedHealth and Salesforce in Focus
Two major components of the Dow Jones Industrial Average have conspicuously lagged behind the broader market through the first half of 2025. These are not small players but established titans facing considerable pressure.
UnitedHealth Group’s Challenges
UnitedHealth Group (NYSE: UNH) has experienced a particularly rough year, with its shares plummeting roughly 40% in value by July 2025, a significant portion of which occurred over a mere 90-day span. This steep decline stems from a confluence of factors:
- Earnings Forecast Reductions: The company faced dramatic reductions in earnings forecasts due to escalating costs and higher claims.
- Department of Justice Investigation: The U.S. Department of Justice launched an investigation into the company for alleged overbilling practices.
- Leadership Change: UnitedHealth’s CEO departed in May, shortly after Wall Street analysts began revising earnings projections downwards.
Despite these headwinds, UnitedHealth Group trades at a relatively low 12.2 times earnings, making it appear cheap on paper. However, investors are advised by sources such as The Motley Fool to thoroughly understand the complex and ongoing situation before considering a position.
Salesforce’s Growth Deceleration
Once a market darling known for consistent double-digit growth, Salesforce (NYSE: CRM) stock lost nearly one-quarter of its value by mid-2025. The core concern for analysts is a significant slowdown in revenue growth. For the current fiscal year, Salesforce is anticipating a 7% to 8% revenue growth rate, marking its first single-digit annual growth rate in years, a sharp contrast to its historical 20% to 30% annual growth rates. Analysts at Bernstein Research, as noted in reports by AOL Finance, express concern that Salesforce may be a mature business in an equally mature market, with prior expectations being overly optimistic.
Nasdaq-100’s Early Year Hurdles: Tech and Consumer Wobbles
January 2025 saw the Nasdaq-100 index make positive strides, yet several of its constituents faced sharp declines, revealing underlying issues in technology and consumer sectors.
- ON Semiconductor (NASDAQ: ON): The biggest loser in January, shares fell 17% following a downgrade from a buy to a hold by a Truist analyst, citing concerns of weak demand.
- Electronic Arts (NASDAQ: EA): Dropped 16% after lowering its full-year revenue forecast due to weaker-than-anticipated demand for its latest soccer video game title.
- Nvidia (NASDAQ: NVDA): Shares declined 10.6%, partly due to the introduction of Deepseek’s AI platform, which promises AI solutions with fewer processors. This new competition has sparked questions about the long-term outlook for Nvidia’s dominant AI processor business.
- Comcast (NASDAQ: CMCSA): Experienced a 10.3% drop, primarily in response to a decline in its broadband customer base during the previous quarter.
- Monster Beverage (NASDAQ: MNST): Down 7.3%, continuing a pullback from an overheated rally that peaked in November 2024.
These varied setbacks highlight that even in a generally bullish market, specific company-centric issues, competitive pressures, and shifting consumer preferences can lead to significant stock underperformance.
Broader Market Retreats: January’s Large-Mid Cap Laggards
A wider lens on the market, looking at the Morningstar US Large-Mid Cap Index, also revealed a list of significant underperformers in January 2025. While the index itself gained 3.1%, certain stocks experienced substantial slides:
- Edison International (NYSE: EIX) slid 31.6%.
- FTAI Aviation (NASDAQ: FTAI) plunged 30.2%.
- Manhattan Associates (NASDAQ: MANH) fell 22.8%.
- PG&E (NYSE: PCG) slid 22.4%.
- Constellation Brands (NYSE: STZ) fell 18.2%.
These companies, primarily in the utilities, industrials, and consumer defensive sectors, demonstrate that market-wide positive sentiment does not insulate every stock from individual pressures or investor reevaluations.
S&P 500’s New “Worst”: Deckers Brands and the Apparel Shake-Up
As of late October 2025, Deckers Brands (NYSE: DECK), the parent company of Hoka and Ugg, earned the unfortunate title of the worst-performing stock in the S&P 500 year to date, with its shares down 56%. This follows a more than 10% plunge after its fiscal second-quarter 2026 financial results.
Previously, advertising technology company The Trade Desk and athletic apparel business Lululemon had held this position, both down 50% or more earlier in the year. The Trade Desk has been navigating its slowest growth period as a publicly traded entity, while Lululemon faced weak demand in key markets and uncertainties from tariffs affecting its cost structure.
What’s Going on with Deckers?
Deckers’ recent woes stem from a revised outlook for fiscal 2026. Management lowered its projected net-sales growth rates for both its key brands:
- Hoka: Outlook revised from mid-teens growth to low-teens.
- Ugg: Outlook revised from mid-single-digit growth to low-single-digit growth.
Furthermore, the company anticipates a decline in its gross margin for fiscal 2026, from an all-time high of 58% in fiscal 2025 to a projected 56%. This margin contraction is attributed, in part, to expense headwinds from tariffs. While some investors fear fading demand leading to lower prices, company statements suggest selling prices are holding up, with tariffs being the primary driver of margin pressure.
Is Deckers a Deep Value Play?
Despite the recent stock plunge, a closer look at Deckers reveals several strengths that suggest investor overreaction. The company’s revenue has more than doubled over the last five years, indicating that the revised growth rates, while lower, don’t necessarily signal a fundamental collapse in demand. Furthermore, Deckers boasts a robust balance sheet with $1.4 billion in cash and zero debt, providing a strong buffer against market uncertainties. Management is also actively repurchasing shares, which helps to boost earnings per share even with moderating revenue growth.
These factors, combined with the stock’s 56% decline, have pushed Deckers’ valuation to its cheapest level in over five years, excluding a brief dip during the early COVID-19 pandemic. Its price-to-earnings (P/E) ratio currently stands at a mere 13, representing approximately a 50% discount to the average stock in the S&P 500. For long-term investors, this dramatic revaluation might present a compelling entry point.
Navigating Volatility: Long-Term Opportunities Amidst Declines
The stories of 2025’s worst-performing stocks serve as a crucial reminder for investors: market-defying sell-offs can be alarming, but not all extreme pullbacks are red flags. Sometimes, they present opportunities to step into compelling stocks at a discount.
Understanding whether a stock’s decline is due to temporary headwinds or a fundamental shift in its business model is paramount. Factors to consider include:
- Balance Sheet Strength: Companies with strong cash positions and low debt are better equipped to weather downturns.
- Valuation: A significant drop can make a stock attractive if its long-term growth prospects remain intact.
- Catalysts for Recovery: Identifying potential factors that could drive a rebound, such as resolution of investigations, new product cycles, or easing of macro pressures.
Insights from Leading Investment Analysis
Investment advisory services frequently analyze market movements, offering perspective on underperforming stocks. For instance, in July 2025, the Motley Fool Stock Advisor analyst team identified what they considered their 10 best stocks for investors to buy, and UnitedHealth Group was not among them. Historically, their recommendations have shown significant returns; an investment of $1,000 when Netflix was listed on December 17, 2004, would have grown to $652,133 by July 15, 2025. Similarly, a $1,000 investment in Nvidia on April 15, 2005, would have yielded $1,056,790 by the same date. The Stock Advisor’s total average return, as of July 15, 2025, was reported at 1,048%, significantly outperforming the S&P 500’s 180% during the same period.
By February 3, 2025, similar historical performance figures were highlighted for stocks that had seen “double down” recommendations. For example, a $1,000 investment in Nvidia following a “double down” recommendation in 2009 would have become $307,661. An investment of the same amount in Apple in 2008 would have reached $44,088, and in Netflix in 2004, it would have grown to $536,525.
Later in October 2025, regarding Deckers Outdoor, the Motley Fool Stock Advisor team again identified their 10 best stocks to buy, but Deckers Outdoor was not included. The historical performance of their picks remained impressive: a $1,000 investment in Netflix on December 17, 2004, would have resulted in $594,569 by October 27, 2025, and a similar investment in Nvidia on April 15, 2005, would have reached $1,232,286 by the same date. The Stock Advisor’s total average return was noted as 1,065%, significantly outpacing the S&P 500’s 196% over their respective tracked periods.
